Drug intelligence / Profile preview

iodine-124 iododeoxyuridine

Development stage
Unknown
Lead developer
Odense Universitetshospital
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intratumoral
01

Overview

Iodine-124 iododeoxyuridine (124I-IUdR) is a radiolabeled thymidine analog used primarily as a positron emission tomography (PET) imaging tracer to visualize and quantify cellular proliferation in tumors. As an analog of thymidine, it is incorporated into the DNA of cells during the S-phase of the cell cycle. This property allows for the assessment of tumor growth kinetics and the distribution of the drug within the tumor microenvironment, particularly in malignant gliomas. It has been investigated for use via convection-enhanced delivery (CED) to bypass the blood-brain barrier. While primarily diagnostic, its incorporation into DNA also suggests potential as a targeted internal radiotherapeutic or radiosensitizer. Research is largely conducted in academic settings, such as Odense University Hospital and the University of Southern Denmark.

Other names
iodine-124 5-iodo-2'-deoxyuridine124I-iododeoxyuridine
02

Targets

DNA

Beyond the preview

Go deeper on iodine-124 iododeoxyuridine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iodine-124 iododeoxyuridine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call